PREDICT HF:利用新型血液动力学参数对晚期心力衰竭进行风险分层

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Nicole Cyrille-Superville MD, Sriram D. Rao MBBS, Jason P. Feliberti MD, Priyesh A. Patel MD, Kamala Swayampakala PhD, Shashank S. Sinha MD, MSc, Eric I. Jeng MD, Rohan M. Goswami MD, David F. Snipelisky MD, Aubrie M. Carroll MD, Samer S. Najjar MD, Mark Belkin MD, Jonathan Grinstein MD, FACC, the FLIGHT Working Group
{"title":"PREDICT HF:利用新型血液动力学参数对晚期心力衰竭进行风险分层","authors":"Nicole Cyrille-Superville MD,&nbsp;Sriram D. Rao MBBS,&nbsp;Jason P. Feliberti MD,&nbsp;Priyesh A. Patel MD,&nbsp;Kamala Swayampakala PhD,&nbsp;Shashank S. Sinha MD, MSc,&nbsp;Eric I. Jeng MD,&nbsp;Rohan M. Goswami MD,&nbsp;David F. Snipelisky MD,&nbsp;Aubrie M. Carroll MD,&nbsp;Samer S. Najjar MD,&nbsp;Mark Belkin MD,&nbsp;Jonathan Grinstein MD, FACC,&nbsp;the FLIGHT Working Group","doi":"10.1002/clc.24277","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Invasive hemodynamics are fundamental in assessing patients with advanced heart failure (HF). Several novel hemodynamic parameters have been studied; however, the relative prognostic potential remains ill-defined.</p>\n </section>\n \n <section>\n \n <h3> Hypothesis</h3>\n \n <p>Advanced hemodynamic parameters provide additional prognostication beyond the standard hemodynamic assessment.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Patients from the PRognostic Evaluation During Invasive CaTheterization for Heart Failure (PREDICT-HF) registry who underwent right heart catheterization (RHC) were included in the analysis. The primary endpoint was survival to orthotopic heart transplant (OHT) or durable left ventricular assist device (LVAD), or death within 6 months of RHC.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of 846 patients included, 176 (21%) met the primary endpoint. In a multivariate model that included traditional hemodynamic variables, pulmonary capillary wedge pressure (PCWP) (OR: 1.10, 1.04−1.15, <i>p</i> &lt; .001), and cardiac index (CI) (OR: 0.86, 0.81−0.92, <i>p</i> &lt; .001) were shown to be predictive of adverse outcomes. In a separate multivariate model that incorporated advanced hemodynamic parameters, cardiac power output (CPO) (OR: 0.76, 0.71−0.83, <i>p</i> &lt; .001), aortic pulsatility index (API) (OR: 0.94, 0.91−0.96, <i>p</i> &lt; .001), and pulmonary artery pulsatility index (OR: 1.02, 1.00−1.03, <i>p</i> .027) were all significantly associated with the primary outcome. Positively concordant API and CPO afforded the best freedom from the endpoint (94.7%), whilst negatively concordant API and CPO had the worst freedom from the endpoint (61.5%, <i>p</i> &lt; .001). Those with discordant API and CPO had similar freedom from the endpoint.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The advanced hemodynamic parameters API and CPO are independently associated with death or the need for OHT or LVAD within 6 months. Further prospective studies are needed to validate these parameters and elucidate their role in patients with advanced HF.</p>\n </section>\n </div>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/clc.24277","citationCount":"0","resultStr":"{\"title\":\"PREDICT HF: Risk stratification in advanced heart failure using novel hemodynamic parameters\",\"authors\":\"Nicole Cyrille-Superville MD,&nbsp;Sriram D. Rao MBBS,&nbsp;Jason P. Feliberti MD,&nbsp;Priyesh A. Patel MD,&nbsp;Kamala Swayampakala PhD,&nbsp;Shashank S. Sinha MD, MSc,&nbsp;Eric I. Jeng MD,&nbsp;Rohan M. Goswami MD,&nbsp;David F. Snipelisky MD,&nbsp;Aubrie M. Carroll MD,&nbsp;Samer S. Najjar MD,&nbsp;Mark Belkin MD,&nbsp;Jonathan Grinstein MD, FACC,&nbsp;the FLIGHT Working Group\",\"doi\":\"10.1002/clc.24277\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Invasive hemodynamics are fundamental in assessing patients with advanced heart failure (HF). Several novel hemodynamic parameters have been studied; however, the relative prognostic potential remains ill-defined.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Hypothesis</h3>\\n \\n <p>Advanced hemodynamic parameters provide additional prognostication beyond the standard hemodynamic assessment.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Patients from the PRognostic Evaluation During Invasive CaTheterization for Heart Failure (PREDICT-HF) registry who underwent right heart catheterization (RHC) were included in the analysis. The primary endpoint was survival to orthotopic heart transplant (OHT) or durable left ventricular assist device (LVAD), or death within 6 months of RHC.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Of 846 patients included, 176 (21%) met the primary endpoint. In a multivariate model that included traditional hemodynamic variables, pulmonary capillary wedge pressure (PCWP) (OR: 1.10, 1.04−1.15, <i>p</i> &lt; .001), and cardiac index (CI) (OR: 0.86, 0.81−0.92, <i>p</i> &lt; .001) were shown to be predictive of adverse outcomes. In a separate multivariate model that incorporated advanced hemodynamic parameters, cardiac power output (CPO) (OR: 0.76, 0.71−0.83, <i>p</i> &lt; .001), aortic pulsatility index (API) (OR: 0.94, 0.91−0.96, <i>p</i> &lt; .001), and pulmonary artery pulsatility index (OR: 1.02, 1.00−1.03, <i>p</i> .027) were all significantly associated with the primary outcome. Positively concordant API and CPO afforded the best freedom from the endpoint (94.7%), whilst negatively concordant API and CPO had the worst freedom from the endpoint (61.5%, <i>p</i> &lt; .001). Those with discordant API and CPO had similar freedom from the endpoint.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>The advanced hemodynamic parameters API and CPO are independently associated with death or the need for OHT or LVAD within 6 months. Further prospective studies are needed to validate these parameters and elucidate their role in patients with advanced HF.</p>\\n </section>\\n </div>\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-06-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/clc.24277\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/clc.24277\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/clc.24277","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

摘要

背景 有创血液动力学是评估晚期心力衰竭(HF)患者的基础。目前已对几种新型血液动力学参数进行了研究,但其相对预后潜力仍不明确。 假设 先进的血液动力学参数可在标准血液动力学评估之外提供额外的预后信息。 方法 将接受右心导管检查(RHC)的心力衰竭介入治疗期间的认知评估(PREDICT-HF)登记患者纳入分析。主要终点是接受正位心脏移植(OHT)或耐用左心室辅助装置(LVAD)后的存活率,或在接受右心导管检查后 6 个月内死亡。 结果 在纳入的846名患者中,176人(21%)达到了主要终点。在包含传统血液动力学变量的多变量模型中,肺毛细血管楔压(PCWP)(OR:1.10,1.04-1.15,p < .001)和心脏指数(CI)(OR:0.86,0.81-0.92,p < .001)被证明是不良结局的预测因素。在一个包含高级血液动力学参数的单独多变量模型中,心脏动力输出(CPO)(OR:0.76,0.71-0.83,p < .001)、主动脉搏动指数(API)(OR:0.94,0.91-0.96,p < .001)和肺动脉搏动指数(OR:1.02,1.00-1.03,p .027)均与主要结果显著相关。API 和 CPO 阳性一致的患者摆脱终点的情况最好(94.7%),而 API 和 CPO 阴性一致的患者摆脱终点的情况最差(61.5%,p < .001)。API和CPO不一致者的终点自由度相似。 结论 先进的血液动力学参数 API 和 CPO 与 6 个月内的死亡或 OHT 或 LVAD 需求独立相关。需要进一步的前瞻性研究来验证这些参数,并阐明它们在晚期 HF 患者中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

PREDICT HF: Risk stratification in advanced heart failure using novel hemodynamic parameters

PREDICT HF: Risk stratification in advanced heart failure using novel hemodynamic parameters

Background

Invasive hemodynamics are fundamental in assessing patients with advanced heart failure (HF). Several novel hemodynamic parameters have been studied; however, the relative prognostic potential remains ill-defined.

Hypothesis

Advanced hemodynamic parameters provide additional prognostication beyond the standard hemodynamic assessment.

Methods

Patients from the PRognostic Evaluation During Invasive CaTheterization for Heart Failure (PREDICT-HF) registry who underwent right heart catheterization (RHC) were included in the analysis. The primary endpoint was survival to orthotopic heart transplant (OHT) or durable left ventricular assist device (LVAD), or death within 6 months of RHC.

Results

Of 846 patients included, 176 (21%) met the primary endpoint. In a multivariate model that included traditional hemodynamic variables, pulmonary capillary wedge pressure (PCWP) (OR: 1.10, 1.04−1.15, p < .001), and cardiac index (CI) (OR: 0.86, 0.81−0.92, p < .001) were shown to be predictive of adverse outcomes. In a separate multivariate model that incorporated advanced hemodynamic parameters, cardiac power output (CPO) (OR: 0.76, 0.71−0.83, p < .001), aortic pulsatility index (API) (OR: 0.94, 0.91−0.96, p < .001), and pulmonary artery pulsatility index (OR: 1.02, 1.00−1.03, p .027) were all significantly associated with the primary outcome. Positively concordant API and CPO afforded the best freedom from the endpoint (94.7%), whilst negatively concordant API and CPO had the worst freedom from the endpoint (61.5%, p < .001). Those with discordant API and CPO had similar freedom from the endpoint.

Conclusion

The advanced hemodynamic parameters API and CPO are independently associated with death or the need for OHT or LVAD within 6 months. Further prospective studies are needed to validate these parameters and elucidate their role in patients with advanced HF.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信